
News|Articles|December 19, 2023
- MHE December 2023
- Volume 33
- Issue 12
State of the Industry: Key Issues, Technology Impact, Presidential Campaign Focus, and Challenges Ahead in 2024
We conducted our annual State of the Industry survey in the early part of November 2023. The survey had 432 respondents, of whom 56% self-reported working for a payer organization (pharmacy benefit manager, insurer or self-insured employer), 34% for a provider organization and the remainder for government or an unspecified “other” category.
Advertisement
Articles in this issue
almost 2 years ago
The Best Hope for Eradicating HCValmost 2 years ago
Biosimilars are Ascendantabout 4 years ago
ICER: More Transparency of Drug Coverage Policies NeededNewsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Positive results for Casgevy but with one patient death from myeloablative busulfan conditioning | ASH 2025
2
Quadruplet treatments for multiple myeloma are rising but access varies | ASH 2025
3
AstraZeneca’s Imfinzi gains landmark FDA approval for early gastric and gastroesophageal cancers
4
IV iron treatment improves survival, increases hemoglobin levels in anemic patients with acute bacterial infection | ASH 2025
5






















































